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Objectives. This study was designed to compare xercise, dipyr- 
idamole and dobutamine eehocardiography in the same patients 
and to evaluate, by measuring physiologic and echocardiographic 
variables, the mechanisms by which exercise and dobutamine 
induce ischemia. 
Background. The diagnostic value of stress eehocardiography 
has been widely reported, but the specific effects of exercise, 
dipyridamole and dobutamine have not been directly compared. 
Furthermore, no echocardiographic study has evaluated left ven- 
tricular volume changes at ischemie threshold uring exercise and 
dobutamine administration. 
Methods. One hundred patients with suspected (Group A, n = 
60) or known (Group B, n = 40) coronary artery disease under- 
went all three tests in random order. 
Results. In Group A, the sensitivities of exercise (mean 76%, 
95% confidence interval [CI] 58% to 94%) and of dobutamine 
echocardiography (72%, 95% CI 53% to 91%) were higher than 
that of dipyridamole (52%, 95% CI 31% to 73%; p = 0.01 and p = 
0.02, respectively). Specificity did not differ significantly among 
tests (94% for exercise [95% CI 86% to 100%] and 97% fiw 
dipyridamole and dobutamine [95% CI 91% to 100%]). Accuracy 
was identical for exercise and dobutamine (87%) and higher than 
that for dipyridamole (78%, p = 0.06). In Group B, the accuracy 
in predicting coronary disease xtent was 71% for exercise, 33% 
for dipyridamole and 75% for dobutamine. At ischemic threshold, 
end-systolic volume index and the ratio of systolic blood pressure 
to end-systolic volume, a variable related to myocardial contrac- 
tility, were significantly lower and higher, respectively, with do- 
butamine than during exercise (p < 0.05). 
Conclusions. In a clinical setting, exercise chocardiography 
should represent the first diagnostic approach because ithas high 
diagnostic efficacy and provides additional information on exer- 
cise capacity; pharmacologic stress, particularly that of dobut- 
amine, provides a pivotal diagnostic tool when exercise is not 
feasible or its results are nondiagnostie. Our preliminary data on 
echocardiographic evaluation at ischemic threshold support he 
view that myocardial contractility is a major factor in inducing 
ischemia during dohutamine infusion. 
(J Am Coil Cardiol 1995;26:18-25) 
The value of two-dimensional echocardiography for detecting 
wall motion abnormalities during physical exercise or pharma- 
cologic stress tests has been widely investigated (1-17). Com- 
pared with exercise testing, pharmacologic tests may have 
several advantages: better quality, of images, feasibility in 
patients unable to exercise and a high specificity and sensitivity 
for the diagnosis of coronary artery disease (6-17). However, 
most studies of stress echocardiography have involved hetero- 
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geneous groups of patients with differences in sample size, 
clinical characteristics and degree of significant coronary ste- 
nosis, making a direct comparison of diagnostic etficacy ditfi- 
cult, and no study has compared exercise, dipyridamole and 
dobutamine chocardiography in the same patients. Further- 
more, although dobutamine and dipyridamole differ in their 
pharmacologic actions (18-20), it has been assumed that 
exercise and dobutamine induce ischemia by increasing myo- 
cardial oxygen demand but their mechanisms of action have 
not been hitherto examined closely. 
The aims of this study were 1) to compare, in the same 
patients, the abiliff of these three stress tests to detect coro- 
nary artery disease in patients with suspected ischemic heart 
disease and to predict he extent of coronary disease in patients 
with previous myocardial infarction; and 2) to delineate, by 
analyzing routine physiologic and echocardiographic variables 
at ischemic threshold, the similarities and differences of exer- 
cise and dobutamine in provoking myocardial ischemia. 
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Methods  
Study patients. We prospectively enrolled in this study 105 
patients with suspected or known coronary artery disease who 
were referred for coronary arteriography for the evaluation of 
chest pain. The study excluded patients with unstable angina, 
congestive heart failure, cardiomyopathy, uncontrolled hyper- 
tension, congenital or acquired valvular heart disease, docu- 
mented serious arrhythmia or previous cardiac surgery. The 
patients were classified into two groups: Group A (64 patients 
[45 men and 19 women, mean age: 55 -+ 8 years]) admitted for 
evaluation of chest pain of suspected myocardial ischemic 
origin without rest wall motion abnormalities and Group B (41 
patients [38 men and 3 women, mean age 53 + 10 years]) with 
previous myocardial infarction with rest wall motion abnormal- 
ities (anterior site in 18 [44%] and inferior site in 23 [56%]) for 
evaluation of the extent of coronary artery disease. Because of 
technical inadequacy ofechocardiographic images, as assessed 
during all three tests, 5 patients were withdrawn from the 
study, leaving 60 patients in Group A and 40 in Group B. 
Cardiac catheterization. Left-sided cardiac atheterization 
and coronary angiography were carried out in all patients in a 
standard manner, For quantitative analysis of coronary artery 
stenoses, a previously described and validated method was 
used (3). Significant coronary, artery stenosis was defined as 
>70% reduction of lumen area in any of the three coronary 
arteries or their primary branches or >50% lumen narrowing 
of the left main coronary artery. Angiograms were reviewed by 
two angiographers who were unaware of the results of stress 
echocardiography. 
Patient scheduling. Each patient underwent, in random 
order, exercise, dipyridamolc and dobutamine cchocardiogra- 
phy, performing the three tests on different days, at the same 
hour and under the same environmental conditions. All stress 
tests were obtained within 2 weeks of cardiac atheterization. 
In patients receiving treatment, beta-adrenergic blocking 
agents were discontinued for >48 h and long-acting nitrates 
and calcium antagonists for >24 h before the tests. The study 
protocol was approved by "La Sapienza" University Ethical 
Committee on Human Research and all patients gave in- 
formed, written consent. 
Exercise echocardiography. Exercise echocardiography 
was performed with supine ergometry on a tilting exercise 
table, with the table tilted to 30 ° of the left lateral decubitus 
position. Exercise was begun with a work load of 20 W that was 
increased by 20 W every 3 rain. Echocardiographic and elec- 
trocardiographic (ECG) monitoring and symptom notation 
were performed throughout testing, with blood pressure deter- 
mined every 3 rain. End points for terminating the test were as 
follows: 1) echocardiographic detection of a wall abnormality 
not present at baseline; 2) symptoms judged to be unaccept- 
able by the supervising cardiologist; 3) myocardial ischemia or 
serious arrhythmia detected by electrocardiography; 4) systolic 
blood pressure >220 mm Hg or diastolic blood pressure 
>120 mm Hg; and 5) exercise-induced xhaustion. Echocar- 
diograms were obtained with a Hewlett-Packard Sonos 1000 
and were digitized on-line at rest and at peak exercise. The 
parasternal long- and short-axis and apical four- and two- 
chamber views of the left ventricle were recorded. Backup 
videotape images were obtained throughout most of each 
exercise step for subsequent determination f ischemic thresh- 
old. 
Dipyridamole and dobutamine chocardiography. Dipyri- 
damole was administered according to a previously described 
protocol (21) as a total dose of 0.84 mg/kg body weight over 
10 rain. Dobutamine was administered with an infusion pump 
at the initial dose of 5 mg/kg per min for 5 rain; the dose was 
increased by 5 mg/kg per rain at 5-rain intervals up to a 
maximal dose of 40 mg/kg per rain. Continuous low speed 
ECG recording was performed and a 12-lead ECG was re- 
corded at 25 mm/s every 2 rain; blood pressure was measured 
by cuff method every. 2rain during and up to 15 rain after drug 
administration. End points for terminating the tests were the 
same as for exercise, except hat the maximal dose of drugs 
replaced exercise-induced xhaustion and the added variable: 
decrease in systolic blood pressure >20 mm Hg. Echocardio- 
grams were obtained with the same equipment and views of the 
left ventricle as described for exercise testing. Updated on-line 
images were digitized at the following four stages: 1) baseline, 
2) low dose, 3) high dose, and 4) 10 min of recovery. Backup 
videotape images were recorded throughout most of each stage 
to determine ischemic threshold. 
Analysis of echocardiograms. The on-line digital images 
were used to diagnose the presence of coronary artery disease, 
its extent and location. The left ventricle was divided into 11 
segments, and wall motion was qualitatively assessed by con- 
ventional methods (22). Segmental wall motion was graded as 
normal, hypokinetic, akinetic or dyskinetic. An abnormal echo- 
cardiographic stress test result was defined as one showing the 
development of a new or worsening stress-induced regional 
wall motion abnormality. Segments of the left ventricle were 
assigned to a three-region scheme of coronary perfusion 
previously reported (15). In patients with localized wall motion 
abnormalities at rest, the location of stress-induced wall mo- 
tion abnormalities was correlated with the location of signifi- 
cantly diseased coronary arteries. In agreement with previous 
reports (23), we considered as homozonal asynergies tress- 
induced new or worsening wall motion abnormalities devel- 
oped within the region supplied by the infarct-related vessel 
that had segments with both normal and abnormal rest wall 
motion, and as remote asynergies the transient asynergies 
developed in territories fed by different coronary arteries and 
having normal wall motion at rest. In selected subgroups of 
patients on the basis of positive exercise and dobutamine t st 
results and adequate image quality for reliable measurements 
(Subgroup A, n = 12; Subgroup B, n = 9), end-diastolic 
volume index, end-systolic volume index and ejection fraction 
were determined by the single-plane area-length method from 
the apical four-chamber view, at rest and during each stage of 
exercise and dobutamine testing. Planimetry of end-systolic 
and end-diastolic areas was performed by manual tracing of 
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Table 1. Sensitivity, Specificity, and Accuracy of Stress-Induced Wall Motion Abnormalities During Exercise, Dipyridamole and Dobutamine 
Echocardiography for the Diagnosis of Corona~ Artery, Disease 
p Value 
Exerc ise D ipyr idamolc  Dobutamine Dipyridamole Dipyridamole Exercise vs. 
No. ¢;- No. ~ No. % Global vs. Exercise vs. Dobutamine Dobutamine 
Sensitivity 
Overall 19/25 76 13/25 52 18/25 72 [I.02 0.01 0.02 NS 
One-vessel CAD 7/10 7(1 3/10 30 6/10 60 {i.04 0.04 0.08 NS 
Multivessel CAD 12/15 811 10/'15 67 12/15 811 NS NS NS NS 
Specificity 33/35 94 34/35 97 34/35 q7 NS NS NS NS 
Accuracy 52/60 87 47/60 78 52/60 87 0.08 0.06 (I.06 NS 
Data are expressed as number or percent of patients or p value. CAD corona U artery disease. 
the endocardial border, including the papillary muscles: Three 
different racings were drawn on each frame, using the mean 
volume for statistical analysis. As a noninvasive index of 
myocardial contractility, the ratio of cuff-determined systolic 
blood pressure to end-systolic volume index was calculated 
(24-26). Echocardiograms were independently reviewed by 
two observers who were unaware of the results of cardiac 
catheterization, with an interobserver agreement on 93% of 
the examined segments. One observer eviewed a random 
sample of 75 studies twice, with an intraobserver agreement on 
97% of the segments reviewed. 
Ischemic threshold. The ischemic threshold was deter- 
mined by echocardiography only, by reviewing the backup 
videotape images: The videotape review frequently showed 
that the ischemic threshold occurred earlier than the time 
indicated by the on-line digital images. The ischemic threshold 
was defined as the point when a new or worsening stress- 
induced wall motion abnormaliW appeared. 
Electrocardiographic analysis. An ischemic response was 
defined as the development of >0.l-mV horizontal or 
downsloping ST segment depression (1.08 s after the J point in 
a lead with a normal baseline ST segment. 
Statistical analysis. Statistical analysis was performed by 
using Statistica for Windows (Statsoft Inc., 1993). Continuous 
variables are expressed as mean value _+ SD; group differences 
were tested by using a paired Student test. Sensitivity, 
specificity and accuracy were calculated in the standard man- 
ner; when appropriate, the 95% confidence intervals were 
computed. Frequency data relative to the three stress tests 
were simultaneously compared by the Cochran Q test for 
matched samples (27): Consistent with a preliminary study, the 
overall significance level (alpha) was set at 0.10. After the 
global Q test, we performed three pairwise comparisons by the 
McNemar chi-square test for dependent samples: A p value 
<0.05 was requested to reject the null hypothesis in each 
pairwise test. Global unpaired comparisons of categoric vari- 
ables were tested by a conditional exact test on 2 x 3 
contingency tables (28), followed by two-sided pairwise com- 
parisons by Fisher exact est; significance l vels were set as for 
the matched comparisons. 
Resu l ts  
Cardiac catheterization. In Group A (n = 60), significant 
coronary artery disease was detected in 25 patients (10 with 
one-vessel and 15 with multivessel disease); absent or insignif- 
icant coronary disease was found in 35 patients. In Group B 
(n -- 40), significant coronary disease was detected in 32 
patients (14 with one-vessel, 18 with multivessel disease) and 
absent or noncritical coronary disease in 8 patients. 
Feasibility and side effects. Feasibility was 100% for phar- 
macologic tests but only 95% (100 of 105 patients) for exercise 
echocardiography because of inadequate xercise imaging. 
During exercise testing, two patients had sustained ventricular 
arrbythmia ssociated with ischemic ECG changes, thus not 
altering the test result. Both pharmacologic tests were well 
tolerated, and there was no major complication during the 
study except for nonsustained ventricular arrhythmia (four 
patients) during dobutamine testing and mild fiypotension 
(two patients) and headache (four patients) during dipyrida- 
mole testing; the latter four patients required aminophylline 
administration. 
Sensitivity and specificity for the diagnosis of coronary 
artery disease (Group A). Of the 25 patients with coronary 
artery disease, 13 had a positive and 4 a negative response to 
all three echocardiographic stress tests. Of the remaining eight 
patients, three had a positive response to both dobutamine and 
exercise chocardiography, three had a positive response only 
to exercise chocardiography and two had a positive response 
only to dobutamine chocardiography. The sensitivities of 
exercise echocardiography (mean 76%, confidence interval 
[CI] 58% to 94%) and dobutamine echocardiography (mean 
72%, CI 53% to 91%) was significantly higher than that of 
dipyridamole chocardiography (52%, CI 31% to 73%; p = 
0.01 vs. exercise and p = 0.02 vs. dobutamine). The sensitivity 
for detecting one-vessel disease was 70% for exercise chocar- 
diographic stress, 60% for dobutamine and 30% for dipyridam- 
ole (exercise vs. dipyridamole, p = 0.04; dobutamine vs. 
dipyridamole, p = 0.08). For detection of multivessel disease, 
no significant differences were observed among the sensitivities 
of exercise (80%), dobutamine (80%) and dipyridamole (67%) 
echocardiography (Table 1). 
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Table 2. Sensitivity and Specificity, of Ischemic Electrocardiographic Changes and Anginal Pain During Exercise, Dipyridamole and 
Dobutamine Echocardiography forthe Diagnosis of Coronary, Artery' Disease 
p Value 
Exercise Dipyridamole Dobutamine Dipyridamole Dipyridamole Exercise vs. 
No. % No. % No. % Global vs, Exercise vs. Dobutamine Dobutamine 
Electrocardiogram 
Sensitivity, 17/25 68 13/25 52 16/25 64 0.15 0.10 NS NS 
Specificity 28/35 80 2(~/35 74 30/35 ~5 (I.05 NS 0.04 NS 
Angina 
Sensitivity 13/25 52 11/25 44 6/25 24 0.03 NS 0.09 0.03 
Specificity 32/35 91 28/35 80 34/35 97 <0.01 0.04 0.01 NS 
Format as in Table 1. 
Specificity was similar for all three stress tests (exercise 
94%, CI 86% to 100%; dipyridamole 97%, CI 91% to 100%; 
dobutamine 97%, CI 91% to 100%). The accuracy of exercise 
and dobutamine chocardiography was identical (87%, CI 
78% to 96%) and higher than that of dipyridamole chocardi- 
ography (78%, CI 68% to 89%; p = (I.06) (Table 1). 
The results of the exercise ECG were positive during all 
three stress tests in 11 patients and negative in 7. The results of 
both exercise and dobutamine ECGs were positive in tour 
patients, 1 patient had a positive result on exercise and 
dipyridamole lectrocardiography and 1 patient had positive 
ECG findings during the two pharmacologic tests; only the 
exercise ECG yielded positive results in one patient. The 
sensitivity of ischemic ECG changes was 68% during exercise 
testing, 52% for dipyridamole and 62% for dobutamine lec- 
trocardiography. The specificity of diagnostic ST segment 
changes was higher during exercise (80%) and dobutamine 
(85%) testing than during dipyridamole infusion (74%, p = 
0.04 vs. dobutamine) (Table 2). 
Anginal pain was absent in 10 patients during all three tests: 
in 4 it was elicited by each of the stress procedures. Angina was 
present only during dobutamine testing in two patients, seven 
patients had both effort- and dipyridamole-induced angina and 
two had pain only during exercise testing. Anginal pain sensi- 
tivity was greater for exercise (52%) and dipyridamole (44%) 
testing than for dobutamine testing (24%, p = 0.03 vs. exercise 
and p = 0.09 vs. dipyridamole). The specificity of anginal 
symptoms developed uring exercise (91%) and dobutamine 
(97%) testing was higher than that during dipyridamole ad- 
ministration (80%, p - 0.04 vs. exercise and p = 0.01 vs. 
dobutamine) (Table 2). 
The chronologic sequence of ischemic responses during 
exercise and dobutamine chocardiography always showed 
that echocardiographic changes occurred earlier than electrical 
and clinical changes; during dipyridamole t sting, in 3 (23%) of 
13 patients the ischemic cascade was altered by the earlier 
appearance of anginal pain when mechanical and electrical 
alterations were still absent. 
E~eacy in detecting the extent of corona~ artery, disease 
(Group B). In patients with previous myocardial infarction 
and abnormal wall motion at rest (Group B), the ability of the 
three tests to detect he extent of significant coronary' artery 
disease was evaluated considering the location of stress- 
induced new wall motion abnormalities. From the initial group 
of 40 patients, those who had diffuse rest wall motion abnor- 
malities involving all three regions of coronary perfusion were 
excluded. Among the remaining 35 patients, wall motion 
abnormalities developed in 14 during exercise testing, in 6 
during dipyridamole testing and in 16 during dobutamine 
testing (Table 3). 
Among patients with a positive exercise test, homozonal 
asynergies were observed in eight patients (57%); five (63%) of 
those had one-vessel disease and three (37%) had multivessel 
disease. Remote asynergy, appeared in six patients (43%); five 
(83%) of those had multivessel disease and one had one-vessel 
disease. Therefore, in patients with localized rest wall motion 
abnormalities, exercise chocardiography predicted the pres- 
ence or absence of a remotely diseased vessel with an accuracy 
of 71% (10 of 14), overestimating the extent of coronary artery 
disease in one patient (7%) and underestimating it in three 
(21%). 
Among patients with a positive dobutamine test result, 
homozona[ asynergies were found in 10 patients (62%); 7 
(70%) of those had one-vessel disease and 3 (30%) had 
multivessel disease. Remote asynergy was found in six patients 
(38%); five (83%) of those bad multivessel disease and one 
(17%) had one-vessel disease. Thus, dobutamine echocardiog- 
raphy correctly indicated the presence or absence of remote 
corona~ disease with an accuracy of 75% (12 of 16), overes- 
Table 3. Accuracy of Exercise, Dipyridamole and Dobutamine 
Echocardiography forPredicting the Extent of Significant Coronary 
Disease in Group B Patients With Rest Wall Motion Abnormalities 
Exercise Diwridamole Dobutamine 
Stress-induced wall motion 14 (40%) 6 (17%) 16 (46%) 
abnormalities 
Correct one-vessel disease 63% 25% 70% 
identification 
Correct multivessel disease 83% 50% 83% 
identification 
Accuracy inpredicting 71% 33% 75% 
CAD extent 
Data are expressed asnumber (%) of patients. CAD = coronary artery 
disease. 
22 DAG1ANTI ET AL. JACC Vol. 26, No. 1 
STRESS ECHOCARDIOGRAPHY July 1995:18-25 
Table 4. Comparison of Physiologic Variables at lschemic Threshold 
Be~'een Exercise and Dobutamine Echocardiography in Patients 
With Stress-Induced Wall Motion Abnormalities During Both Tests 
Group A (n 16) Group B (n 12) 
Exercise Dobutaminc Exercise Dobutamine 
Heart rate 
(bcats/min) 
Systolic blood 
pressure 
(mm Hg) 
Rate-pressure 
product 
(beats/rain 
×mm Hg 
x 11) 3) 
104 + 17 II0 + 211 132 : 15 121 + 24 
lg0 + 33* 143 - 14 185 : 28* 134 + 28 
19.2 : 6.5? 15.4 + 2.1 24.3 +~ 4.7* 16.0 + 5.7 
*p < 0.01 versus dobutaminc, fp < 11.05 versus dobutamine. Data arc 
expressed asmean value + SD. Group A - patients with suspected coronary 
arte O, disease without rest wall motion abnormalities; Group B - patients with 
previous myocardial infarction and rest wall motion abnormalilies. 
timating the extent of disease in one patient (6%) and under- 
estimating it in three (19%). 
Among patients with a positive dipyridamole test result, 
homozonal asynergies were imaged in four patients (67%), 
including three (75%) with multivessel disease. In two patients 
(33%) a remote asynergy developed, one (50%) with multi- 
vessel disease and the other with one-vessel disease. Thus, the 
accuracy of dipyridamole chocardiography in predicting the 
presence or absence of remote coronary disease was 33% (two 
of six) (p = 0.13 vs. dobutamine and p - 0.16 vs. exercise), 
overestimating the extent of coronary disease in one patient 
(26%) and underestimating it in three (50%). 
Ischemic threshold. The comparison of physiologic vari- 
ables at ischemic threshold between exercise and dobutamine 
testing was performed only in patients who had true positive 
results on both tests in Group A (n = 16) and Group B (n - 
12). In Group A, the significantly higher rate-pressure product 
for exercise (exercise 19.2 _+ 6.5 vs. dobutamine 15.4 + 2.1 
beats/rain ×mm Hg x 103, p < 0.05) was due to significantly 
higher systolic blood pressure (exercise 180 + 33 vs. debut- 
amine 143 _+ 14 mm Hg, p < 0.01) with no significant 
differences in heart rate (exercise 104 _+ 17 vs. dobutaminc 
110 _+ 20 beats/rain, p - NS). In Group B, the higher ratc- 
pressure product for exercise (exercise 24.3 _+ 4.7 vs. debut- 
amine 16.6 _+ 5.7 beats/rain x mm Hg × 103, p < 0.01) was due 
to higher systolic blood pressure (exercise 185 _+ 28 vs. 
dobutamine 134 + 28 mm Hg, p < 0.01), whereas the 
difference in heart rate was not statistically significant (exercise 
132 _+ 15 vs. dobutamine 121 + 24 beats/rain, p = NS) (Table 
4). 
The evaluation of echocardiographic variables, including 
end-diastolic volume index, end-systolic volume index, as well 
as of ejection fraction and the ratio of systolic blood pressure 
to end-systolic volume index, obtained during exercise and 
dobutamine echocardiography in the selected subgroups of 
patients with both tests positive and adequate image quality (as 
Table 5. Comparison of Selected Hemodynamic Variables at Rest 
and at Ischemic Threshold (Peak Stress) Between Exercise and 
Dobutamine Echocardiography in Selected Subgroups of Patients 
With Stress-Induced Wall Motion Abnormalities During Both Tests 
Subgroup A (n = 12) Subgroup B (n = 9) 
Exercise Dobutamine Exercise Dobutamine 
EDVI (ml/m 2) 
Rest 92 ± 18 
Peak stress 88 + 19 
ESVI (ml/m ~) 
Rest 44 -+ 12 
Peak slress 39 + 11' 
EF (9~) 
Rest 52- 10 
Peak stress 60 ± 8 
SBP/ESVI 
Rest 3.04 + 0.9 
Peak stress 4.6 _+ 1.3' 
91 + 17 95 + 20 94 + 22 
82 +- 14 92 + 19 88_+ 13 
46 + 14 5(I + 1l 52_ + 10 
30 _+ 9 49 _+ 8* 40 _+ 10 
50_+ ll 50-+10 52_+9 
64 + 6 54 + 8 56 + 9 
3.05 = 1.4 3.06 + 0.7 3.02 _+ 0.9 
5.2 ~ 2.3 4.2 + 1.2' 5.7 _+ 1.1 
*p < 0.05 versus dobutamine. Data arc expressed as mean value + SD. 
EDVI and ESVI = left ventricular end-diastolic and end-systolic volume index, 
respectively; EF = ejection fraction; SBP - systolic blood pressure; Subgroups 
A and B selected patients from Groups A and B (as defined in Table 4). 
in Methods), showed no significant differences at baseline in 
Subgroup A (n = 12) and Subgroup B (n : 9) (Table 5). At 
ischemic threshold, there was no significant difference relative 
to end-diastolic volume index (Subgroup A: exercise 88 _+ 19 
vs. dobutamine 82 _+ 14 ml/m 2, p = NS; Subgroup B: exercise 
92 _+ 19 vs. dobutamine 88 _+ 13 ml/m x, p = NS) and ejection 
fraction (Subgroup A: exercise 60 _+ 8% vs. dobutamine 64 _+ 
6%, p = NS; Subgroup B: exercise 54 _+ 8% vs. dobutamine 
56 _+ 9%, p - NS). However, during exercise echocardiogra- 
phy we observed greater end-systolic volume index (Subgroup 
A: exercise 39 -+ 11 vs. dobutaminc 30 _+ 9 ml/m 2, p < 0.05; 
Subgroup B: exercise 49 _+ 8 vs. dobutamine 40 _+ 10 ml/m 2, 
p < 0.05) and lower ratio of systolic blood pressure to 
end-systolic volume index (Subgroup A: exercise 4.6 _+ 1.3 vs. 
dobutamine 5.2 _+ 2.3 mm Hg/ml per m 2, p < 0.05; Subgroup 
B: exercise 4.2 _+ 1.2 vs. dobutamine 5.7 + 1.1 mm Hg/ml per 
m 2, p < 0.05) (Table 5). 
Discuss ion  
One of the original aspects of this study is the direct 
comparison in the same patients of the three echocardio- 
graphic stress modalities more widely used in the evaluation of 
patients with suspected or known coronary artery disease, an 
approach lacking in the otherwise rich literature on echocar- 
diographic stress (7,9,12-17). Furthermore, the reported stud- 
ies often did not distinguish between patients with and without 
rest wall motion abnormalities, thus making data interpreta- 
tion difficult. In fact, patients with and without previous 
myocardial infarction represent wo distinct groups with dif- 
ferences not only in pathophysiologic background but also in 
the required technical and methodologic approach. 
Patients with suspected coronary artery, disease. In this 
study, all three echocardiographic stress tests showed optimal 
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feasibility with no relevant side effects, with exercise and 
dobutamine chocardiography demonstrating a higher sensi~ 
tivity than dipyridamole echocardiography for the diagnosis of 
coronary artery disease. Several previous clinical studies (7,13- 
15,17) have compared obutamine and dipyridamole chocar- 
diography, globally reporting a trend toward a greater sensi- 
tivity of dobutamine and a slightly higher specificity of 
dipyridamole. In a study comparing exercise with dobutamine 
echocardiography (9), the efficacy for detection of coronary 
disease was similar, both overall and across angiographic 
subgroups; similar sensitivity levels for exercise (76%) and 
dipyridamole (72%) were reported by Picano et al. (12), 
whereas Marangelli et al. (16) recently obtained significantly 
higher sensitivity values for exercise (89%) than for dipyrida- 
mole (43%). Even if the difference in diagnostic values is 
mainly due to the significantly higher sensitivity of dobutamine 
and exercise with respect o dipyridamole in detecting one- 
vessel coronary disease, dipyridamole chocardiography also 
appears to be less sensitive in patients with multivessel disease 
(29,30). 
As indicated by experimental (20) and clinical (31) findings, 
these results suggest that diwridamole infusion requires a 
particular anatomic oronary condition to have an ischemia- 
inducing effect. The high sensitivity values reported by Picano 
et al. (11,12) may be related to differences in clinical charac- 
teristics of study groups: Only in patients with a severe 
reduction of coronary reserve can dipyridamole-induced flow 
maldistribution, in the presence of only slight increases in 
myocardial oxygen consumption, induce an unbalance between 
oxygen demand and supply severe enough to produce echo- 
cardiographically detectable myocardial ischemia. The sensi- 
tivity of dipyridamole echocardiography in our study is similar 
to that found by other investigators (13,15,16,29,30) and 
compares well with that obtained for adenosine chocardiog- 
raphy by Marwick et al. (32). In our previous investigations 
dipyridamole chocardiographic stress sensitivity in the diag- 
nosis of multivessel disease was improved by using echocardio- 
graphic Doppler variables (21) and by the transesophageal 
approach (33). In the present study, our data on the sensitivity 
and accuracy of dobutamine chocardiography are similar to 
those previously reported (7,9,10,13,15,17), The sensitivity of 
exercise echocardiography observed in our patients was in 
keeping with the results obtained uring our experience with 
this technique, over several years (2-4). These clinical findings 
agree with the results of a recent experimental study by 
Paulsen et al. (34), who demonstrated that physical exercise 
was a better stress than dipyridamole, dobutamine or pacing, 
causing the most severe regional contractile dysfunction i  the 
presence of coronary stenosis. 
All three tests in the present study demonstrated high 
specificity for diagnosing coronary artery disease. These re- 
sults, in keeping with most previous reports (1-17), underline 
the diagnostic reliability of reversible abnormal wall motion as 
a marker of myocardial ischemia more specific than ECG 
changes and anginal pain. They also confirm our previous data 
(2) showing that the sensitivity and specificity of ECG changes 
and anginal symptoms are lower than those of the appearance 
of new wall motion abnormalities. Similarly, they confirm our 
previous results relative to anginal pain during dipyridamole 
stress: As already observed, this symptom is quite nonspecific 
and in some tests with positive findings precedes echocardio- 
graphic and ECG changes, thus altering the well known 
ischemic ascade. This behavior can be explained by the action 
of dipyridamole on the timing and quantity of adenosine 
bioavailability, leading to flow maldistribution and changes in 
perception of anginal pain. 
Patients with previous myocardial infarction. Few studies 
have directly compared ifferent stress modalities for predict- 
ing the extent and severity of coronary artery disease in the 
same patients with previous myocardial infarction and rest wall 
motion abnormalities. In a prospective study, Mertes et al. (35) 
reported a comparable accuracy for exercise and dobutamine 
echocardiography in patients with recent myocardial infarc- 
tion. In our study dobutamine and exercise echocardiography 
also had similar levels of accuracy, with respective values in 
keeping with those previously reported (6,36,37); however, the 
accuracy of dipyridamole chocardiography was less than that 
of the other two tests. In a previous comparison of dipyrida- 
mole and dobutamine chocardiography, Salustri et al. (14) 
reported analogous ensitivities for detection of myocardial 
ischemia in patients with rest wall motion abnormalities; 
however, their dobutamine t sts were performed in a relevant 
proportion of patients during beta-blocker administration, 
which may have reduced the diagnostic value of the dobut- 
amine test, whereas our data were obtained in patients who 
were not receiving therapy. In a recent study by Previtali et al. 
(15), performed after discontinuation of antianginal therapy, 
the accuracy of dobutamine and dipyridamole chocardiogra- 
phy in assessing extent of coronary disease in patients with 
asynergy at rest did not differ significantly. 
Although our data point to a trend toward a statistically 
significant difference between the accuracy of both exercise 
and dobutamine chocardiography and that of dipyridamole 
echocardiography, a larger study group would be needed to 
show significance. 
The high accuracy of dobutamine testing, comparable to 
that of exercise echocardiography, could be ascribed to tech- 
nical and pathophysiologic fa tors. During dobutamine t sting, 
fewer artifacts due to body movement and respiration occur, a 
factor that can affect image analysis, particularly in patients 
with wall motion abnormalities at rest. Furthermore, the 
mechanism by which dobutamine induces myocardial ischemia 
may differ from that of exercise and influence sensitivity. 
The inaccuracies of stress echocardiography in predicting 
the extent of coronary artery disease deserve further general 
consideration. The underestimation f multivessel disease may 
occur in part because the test uses stress-induced wall motion 
abnormality as an end point; therefore, the development of 
remote asynergy can be missed if a test is interrupted early in 
response to homozonal new asynergy. The overestimation is 
related to the limitations of the comparison between functional 
(transient wall motion abnormality) and anatomic (coronary 
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stenosis) findings: Coronary arteriography represents the ref- 
erence standard for coronary artery disease but not for myo- 
cardial ischemia, and the presence of stress-induced myocar- 
dial ischemia is relatively independent of the severity and 
extent of coronary stenoses. The true reference standard could 
be the mechanical dysfunction, a point of view supported by 
previous investigations (38) on the concordance between me- 
chanical and metabolic markers of ischemia. 
Differences in pathophysiologic mechanisms of ischemia. 
The other important finding of this study was the significant 
difference between dobutamine and exercise chocardiography 
in physiologic and echocardiographic variables at ischemic 
threshold. Cohen et al. (9) first reported significant differences 
in heart rate, systolic blood pressure and rate-pressure product 
values at ischemic threshold between dobutamine and exercise 
echocardiography, finding that heart rate had a more impor- 
tant role in causing ischemia during exercise than during 
dobutamine t sting. Our results agree only in part with these 
data because they demonstrate a more relevant role for systolic 
blood pressure during exercise chocardiography. These dif- 
ferences could be ascribed to our study's use of the supine 
decubitus position, which may allow the ischemic threshold to 
occur at a lesser heart rate (39) because of the increase in 
venous return, central blood volume and, consequently, left 
ventricular wall stress. 
A recent clinical study (40) supports the importance of 
increased myocardial contractility during dobutamine stress 
echocardiography. Moreover, experimental investigations in
dogs (41,42) showed that the physiologic increase in myocar- 
dial contractility was 82% with exercise and 125% with dobut- 
amine testing; with coronary occlusion, contractility increased 
by 32% with dobutamine but decreased by 63% with exercise 
testing. Therefore, in those patients in whom ischemia was 
induced at a lower heart rate, blood pressure and rate-pressure 
product with dobutamine than with exercise, one may infer 
that pharmacologic stress testing causes a greater increase in 
myocardial contractility. 
Insight on this issue can be obtained by our present findings 
on the behavior of left ventricular volumes and of a noninva- 
sive indirect index of myocardial contractility during dobut- 
amine and exercise testing. Previous studies addressed the 
usefulness of evaluating left ventricular volume changes (43) 
and the ratio of systolic blood pressure to end-systolic volume 
(25,26) during exercise for diagnostic and functional assess- 
ment of patients with coronary artery disease. Moreover, 
abnormal responses of the left ventricular cavity area to 
dobutamine infusion have been observed with echocardiogra- 
phy (40) in patients with coronary disease. However, our study 
is the first to report preliminary data directly comparing 
volume measurements in the same patients during both dobut- 
amine and exercise chocardiography, with the aim of obtain- 
ing pathophysiologic information on myocardial contractility. 
The finding of a significantly lower ventricular end-systolic 
volume index and a higher atio of systolic blood pressure to 
end-systolic volume index at ischemic threshold uring dobut- 
amine infusion than during physical exercise supports the 
above-mentioned hypothesis that contractility is a major con- 
tributor to myocardial oxygen consumption and stress-induced 
ischemia during this pharmacologic test. The greater influence 
of dobutamine on contractility, in comparison with that of 
exercise, can also explain the positive response to this phar- 
macologic test in those patients with negative xercise cho- 
cardiographic results despite the higher heart rate, systolic 
blood pressure and rate-pressure product reached uring the 
exercise test. 
Clinical implications. On the basis of these results, we 
believe that in a routine clinical setting for the identification of 
coronary artery disease, physical stress testing should represent 
the first diagnostic approach because of its high diagnostic 
value and its physiologic means of stressing the cardiovascular 
system: Duration of exercise, increase in heart rate, blood 
pressure response and reproduction of symptoms represent 
complementary functional data that should be considered and 
incorporated with cardiac imaging results. Furthermore, there 
are economic reasons for this methodologic approach: Al- 
though exercise lectrocardiography remains the most com- 
mon approach for screening patients with a chest pain syn- 
drome, ECG patterns have limitations because of their 
relatively low sensitivity and specificity and inability to detect 
the site and extent of ischemia; however, the development of 
digital technology and the consequent improvement of echo- 
cardiographic exercise images have rendered the conjunction 
of exercise ECG testing with the relatively inexpensive cho- 
cardiogram a befitting means of enhancing diagnostic efficacy 
and reducing the cost/benefit ratio. 
Pharmacologic stress tests, although easier to perform, are 
not functional or physiologic tests, are generally less accepted 
by patients and can have unpleasant side effects and persistent 
ischemia-producing effects. For these reasons they should not 
be considered the first step in the diagnostic setting but a 
pivotal diagnostic tool for patients unable to exercise or for 
whom exercise chocardiography is nondiagnostic. In particu- 
lar, dobutamine echocardiographic stress more closely approx- 
imates physical stress in its induction of ischemia through an 
increase of myocardial oxygen demand, as well as its similar 
sensitivity and accuracy values, and it can play a complemen- 
tar':' role in confirming a negative xercise test result or in 
unmasking false negative responses to exercise. Dipyridamole 
echocardiography has been extensively evaluated and widely 
used for the diagnosis of coronary artery disease; however, 
from our direct comparison ofdipyridamole with the other two 
stress tests, the former seems less useful as a routine diagnostic 
tool yet particularly valid in the pathophysiologic field for 
recognizing particular functional abnormalities of major coro- 
nary arteries and small resistance vessels. 
Although these considerations may suggest valid clinical 
guidelines relative to the three tests, we are aware that 
comparative data on larger groups of patients are needed. 
With such data, it may be possible not only to confirm the 
preliminary findings of this study, but also to better define the 
cost/benefit ratio of pharmacologic stress echocardiography 
versus exercise chocardiography. 
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